Deoxyguanosine adducts of t-4-Hydroxy-2-nonenal are endogenous DNA lesions in rodents and humans: Detection and potential sources

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1507-1511

  Chung, Fung Lung ^a   Nath, Raghu G ^a,c   Ocando, Joseph ^a   Nishikawa, Akiyoshi ^b   Zhang, Lei ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^c Department of Genetic and Molecular Toxicology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; ARTICLE; CANCER; CONTROLLED STUDY; DNA DAMAGE; FATTY ACID METABOLISM; HUMAN; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ALDEHYDES; ANIMALS; CARBON TETRACHLORIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLON; DEOXYGUANOSINE; DNA; DNA ADDUCTS; HUMANS; LIPID PEROXIDATION; LIVER; MALE; RATS; RATS, INBRED F344;

EID: 0034654638     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Halliwell, B., and Gutteridge, J. M. Role of free radicals and catalytic metal in human disease: an overview. Methods Enzymol., 186: 1-85, 1990.
2. Esterbauer, H., Zollner, H., and Schaur, R. J. Aldehydes formed by lipid peroxidation: mechanisms of formation, occurrence, and determination. In: C. Vigo-Pelfrey (ed.), Membrane Lipid Oxidation, Vol. 1, pp. 239-283. Boca Raton, FL: CRC Press, Inc., 1990.
3. Wu, H-Y., and Lin, J-K. Determination of aldehydic lipid peroxidation products with dabsylhydrazine by high-performance liquid chromatography. Anal. Chem., 67: 1603-1612, 1995.
4. Esterbauer, H., Schaur, R. J., and Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 11: 81-128, 1991.
5. Witz, G. Biological interactions of α, β-unsaturated aldehydes. Free Radic. Biol. Med., 7: 333-349, 1989.
6. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res., 44: 990-995, 1984.
7. Winter, C. K., Segall, H. J., and Haddon, W. F. Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res., 4: 5682-5686, 1986.
8. 2-(1,3-propano)-2-deoxyguanosine 3′-phosphate adducts formed from 4-hydroxy-2-nonenal. Chem. Res. Toxicol., 10: 1259-1265, 1997.
9. 2-propanodeoxyguanosine adducts as common DNA lesions in rodents and humans. Proc. Natl. Acad. Sci. USA, 91: 7491-7498, 1994.
10. 2-propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues. Cancer Res., 56: 452-456, 1996.
11. Chung, F-L., Chen, H-J. C., and Nath, R. G. Lipid peroxidation as a potential endogenous source for the formation of exocyclic DNA adducts: a commentary. Carcinogenesis (Lond.), 17: 2105-2111, 1996.
12. Schaur, R. J., Zollner, H., and Esterbauer, H. Biological effects of aldehydes with particular attention to 4-hydroxynonenal and malonaldehyde. In: C. Vigo-Pelfrey (ed.), Membrane Lipid Oxidation, Vol. 3, pp. 141-163. Boca Raton, FL: CRC Press, Inc., 1991.
13. Esterbauer, H., Gebicki, J., Puhl, H., and Jurgens, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med., 13: 341-390, 1992.
14. Bolgar, M. S., Yang, C. Y., and Gaskell, S. J. First direct evidence for lipid/protein conjugation in oxidized human low density lipoprotein. J. Biol. Chem., 271: 27999-28001, 1996.
15. Uchida, K., Toyokuni, S., Nishikawa, K., Kawakishi, S., Oda, H., Hiai, H., and Stadtman, E. R. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Biochemistry, 33: 12487-12494, 1994.
16. Uchida, K., and Stadtman, E. R. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem., 268: 6388-6393, 1993.
17. Friguet, B., Stadtman, E. R., and Seweda, L. I. Modification of glucose-6-phosphate dehydrogenase by 40-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J. Biol. Chem., 269: 21639-21643, 1994.
18. Sayre, L. M., Sha, W., Xu, G., Kaur, K., Nadkami, D. Subbanagounder, G., and Salomon, R. G. Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenal. Chem. Res. Toxicol., 9: 1194-1201, 1996.
19. Bruenner, B. A., Jones, A. D., and German, J. B. Direct characterization of protein adducts of the lipid peroxidation product 4-hydroxy-2-nonenal using electrospray mass spectrometry. Chem. Res. Toxicol., 8: 552-559, 1995.
20. Montine, T. J., Huang, D. Y., Valentine, W. M., Amarnath, V., Saunders, A., Weisburger, K. H., Graham, D. G., and Strittmatter, W. J. Crosslinking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol., 55: 202-210, 1996.
21. Bestervelt, L. L., Vaz, A. D. N., and Coon, M. J. Inactivation of ethanol-inducible cytochrome P450 and other microsomal P450 isozymes by trans-4-hydroxy-2-nonenal, a major product of membrane lipid peroxidation. Proc. Natl. Acad. Sci. USA, 92: 3764-3768, 1995.
22. Cohn, J. A., Tsai, L., Friguot, B., and Seweda, L. I. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. Arch. Biochem. Biophys., 328: 158-164, 1996.
23. Uchida, K., Itakura, K., Kawakishi, S., Hiai, H., Toyokuni, S., and Stadtman, E. R. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys., 324: 241-248, 1995.
24. Hartley, D. P., Kroll, D. J., and Petersen, D. R. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehydeprotein adducts. Chem. Res. Toxicol., 10: 895-905, 1997.
25. Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., and Mizuno, Y. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc. Natl. Acad. Sci. USA, 93: 2696-2701, 1996.
26. Uchida, K., Szweda, L. I., Chae, H-Z., and Stadtman, E. R. Immunochemical detection of 4-hydroxynonenal protein adducts in oxidized hepatocytes. Proc Natl. Acad. Sci. USA, 90: 8742-8746, 1993.
27. Montine, K. S., Kim, P. J., Olson, S. J., Markesberg, W. R., and Montine, T. J. 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol. Exp. Neurol., 56: 866-871, 1997.
28. Montine, K. S., Olson, S. J., Amarnath, V., Whetsell, W. O., Jr., Graham, D. G., and Montine, T. J. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol., 150: 437-443, 1997.
29. Zarkovic, N., Tillian, M. H., Schaur, R. J., Wang, G., Jurin, M., and Esterbauer, H. Inhibition of melanoma B16-F10 growth by lipid peroxidation product 4-hydroxynonenal. Cancer Biother., 10: 153-156, 1995.
30. Poljak-Blazi, M., Zarkovic, N., and Schaur, R. J. Impaired proliferation and DNA synthesis of a human tumor cell line (HeLa) caused by short treatment with the antianemic drug jectofer (ferric-sorbitol-citrate) and the lipid peroxidation product 4-hydroxynonenal. Cancer Biother. Radiopharm., 13: 395-402, 1998.
31. Fazio, V. M., Barrera, G., Martinotti, S., Farace, M. G., Giglioni, B., Frati, L., Manzari, V., and Dianzani, M. U. 4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and glohin gene expression in K562 erythroleukemic cells. Cancer Res., 52: 4866-4871, 1992.
32. Kreuzer, T., Grube, R., Wutte, A., Zarkovic, N., and Schaur, R. J. 4-Hydroxynonenal modifies the effects of serum growth factors on the expression of the c-fos protooncogene and the proliferation of HeLa carcinoma cells. Free Radic. Biol. Med., 25: 42-49, 1998.
33. Marmur, J. Procedure for the isolation of deoxyribonucleic acid from micro-organisms. J. Mol. Biol., 3: 208-218, 1961.
34. Alary, J., Bravais, F., Cravedi, J-P., Debrauwer, L., Rao, D., and Bories, G. Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat. Chem. Res. Toxicol., 8: 34-39, 1995.
35. Dosanjh, M. K., Chenna, A., Kim, E., Fraenkel-Conrat, H., Samson, L., and Singer, B. All four known cyclic adducts formed by the vinyl chloride metabolite chloroacetaldehyde are released by a human DNA glycosylase. Proc. Natl. Acad. Sci. USA, 91: 1024-1028, 1994.
36. 2,3-ethenoguanine from chloroacetaldehyde-treated DNA by Escherichia coli 3-methyladenine DNA glycosylase II. Proc. Natl. Acad. Sci. USA, 89: 9331-9334, 1992.
37. Johnson, K. A., Fink, S. P., and Marnett, L. J. Repair of propanodeoxyguanosine by nucleotide excision repair in vivo and in vitro. J. Biol. Chem., 17: 11434-11438, 1997.
38. Klaassen, C. D., and Plaa, G. L Comparison of biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,2,1-trichloroethane. Biochem. Pharmacol., 18: 2019-2027, 1969.
39. Cajelli, E., Ferraris, A., and Brambilla, G. Mutagenicity of 4-hydroxynonenal in V79 Chinese hamster cells. Mutat. Res., 190: 169-171, 1987.
40. Benamira, M., Singh, U., and Marnett, L. J. Site-specific frameshift mutagenesis by a propanodeoxyguanosine adduct positioned in the (CpG)4 hot-spot of Salmonella typhimurium hisD3052 carried on an M13 vector. J. Biol. Chem., 267: 22392-22400, 1992.
41. Moriya, M., Zhang, W., Johnson, F., and Grollman, A. P. Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc. Natl. Acad. Sci. USA. 91: 11899-11903, 1994.
42. Chung, F-L., Chen, H-J. C., Guttenplan, J. B., Nishikawa, A., and Hard, G. C. 2,3-Epoxy-4-hydroxynonanal as a potential tumor-initiating agent of lipid peroxidation. Carcinogenesis (Lond.), 14: 2073-2077, 1993.
43. Trush, M. A., and Kensler, T. W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med., 10: 201-209, 1991.